|
EXAS
|
Exact Sciences Corporation
|
11.64%
|
US
|
NASDAQ
|
|
IONS
|
Ionis Pharmaceuticals, Inc.
|
5.34%
|
US
|
NASDAQ
|
|
PACB
|
Pacific Biosciences of California, Inc.
|
4.76%
|
US
|
NASDAQ
|
|
TDOC
|
Teladoc, Inc.
|
4.47%
|
US
|
NYSE
|
|
INCY
|
Incyte Corporation
|
4.04%
|
US
|
NASDAQ
|
|
BEAM
|
Beam Therapeutics Inc.
|
4.03%
|
US
|
NASDAQ
|
|
DNA
|
Ginkgo Bioworks Holdings, Inc.
|
3.89%
|
US
|
NYSE
|
|
SDGR
|
Schrodinger, Inc.
|
3.81%
|
US
|
NASDAQ
|
|
CDNA
|
CareDx, Inc.
|
3.74%
|
US
|
NASDAQ
|
|
ADPT
|
Adaptive Biotechnologies Corporation
|
3.72%
|
US
|
NASDAQ
|
|
CRSP
|
CRISPR Therapeutics AG
|
3.41%
|
US
|
NASDAQ
|
|
NTLA
|
Intellia Therapeutics, Inc.
|
3.34%
|
US
|
NASDAQ
|
|
TWST
|
Twist Bioscience Corporation
|
3.08%
|
US
|
NASDAQ
|
|
VCYT
|
Veracyte, Inc.
|
2.82%
|
US
|
NASDAQ
|
|
VERV
|
Verve Therapeutics, Inc.
|
2.73%
|
US
|
NASDAQ
|
|
ACCD
|
Accolade, Inc.
|
2.25%
|
US
|
NASDAQ
|
|
PATH
|
UiPath, Inc.
|
2.08%
|
US
|
NYSE
|
|
RPTX
|
Repare Therapeutics Inc.
|
1.89%
|
US
|
NASDAQ
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
1.87%
|
US
|
NASDAQ
|
|
VEEV
|
Veeva Systems Inc.
|
1.81%
|
US
|
NYSE
|